Cargando…

Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants

Detalles Bibliográficos
Autores principales:	Lechien, Jérôme R, Saussez, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397299/ https://www.ncbi.nlm.nih.gov/pubmed/34461055 http://dx.doi.org/10.1016/S1473-3099(21)00474-6

Ejemplares similares

The study of olfactory dysfunction in SARS-CoV-2 variants
por: Vaira, Luigi A., et al.
Publicado: (2022)

Importance of precise data on SARS-CoV-2 transmission dynamics control
por: Rybniker, Jan, et al.
Publicado: (2020)

SARS-CoV-2 variants and considerations of inferring causality on disease severity
por: Cevik, Muge, et al.
Publicado: (2021)

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2
por: Radulesco, Thomas, et al.
Publicado: (2021)

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
por: Markov, Peter V., et al.
Publicado: (2022)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Assessing the potential for fomite transmission of SARS-CoV-2
por: Short, Kirsty R, et al.
Publicado: (2023)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2?
por: Hamilton, Fergus, et al.
Publicado: (2021)

Targeted mass testing and phylogenetic analysis is effective for preventing community transmission of SARS‐CoV‐2 beta variant
por: Tokuda, Yasuharu, et al.
Publicado: (2022)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

Ten scientific reasons in support of airborne transmission of SARS-CoV-2
por: Greenhalgh, Trisha, et al.
Publicado: (2021)

The role of schools and school-aged children in SARS-CoV-2 transmission
por: Flasche, Stefan, et al.
Publicado: (2021)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?
por: Yeo, Charleen, et al.
Publicado: (2020)

Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission
por: Somsen, G Aernout, et al.
Publicado: (2020)

Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2
por: Pitzer, Virginia E, et al.
Publicado: (2020)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
por: Hoehl, Sebastian, et al.
Publicado: (2023)

ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
por: Descamps, Géraldine, et al.
Publicado: (2020)

Tracking the transmission and evolution of MERS-CoV
por: Hui, David S
Publicado: (2013)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Travel measures in the SARS-CoV-2 variant era need clear objectives
por: Kucharski, Adam J, et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

Understanding how fast SARS-CoV-2 variants transmit from household studies
por: Yang, Yang, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

SARS-CoV-2 severity in African Americans – a role for Duffy null?
por: Hebbel, Robert P., et al.
Publicado: (2020)

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission
por: Fearon, Elizabeth, et al.
Publicado: (2021)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7h6166nhst7jv1hhv3qb73nid1